Crosstalk between angiogenesis and immune regulation in the tumor microenvironment

被引:46
作者
Kim, Hei Jung [1 ]
Ji, Young Rae [2 ]
Lee, You Mie [1 ,3 ]
机构
[1] Kyungpook Natl Univ, Vessel Organ Interact Res Ctr, VOICE MRC, 80 Daehak Ro, Daegu 41566, South Korea
[2] Natl Inst Deafness & Other Commun Disorders, NIH, Bethesda, MD USA
[3] Kyungpook Natl Univ, Coll Pharm, Res Inst Pharmaceut Sci, Dept Mol Pathophysiol, 80 Daehak Ro, Daegu 41566, South Korea
基金
新加坡国家研究基金会;
关键词
Tumor microenvironment; Angiogenesis; Immune suppressive tumor; Tumor-associated macrophage; Treg cells; ENDOTHELIAL GROWTH-FACTOR; CD8(+) T-CELLS; HYPOXIA-INDUCIBLE FACTORS; NATURAL-KILLER-CELLS; SUPPRESSOR-CELLS; DENDRITIC CELLS; NK CELLS; B-CELLS; PERIPHERAL-BLOOD; VESSEL NORMALIZATION;
D O I
10.1007/s12272-022-01389-z
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Cancer creates a complex tumor microenvironment (TME) composed of immune cells, stromal cells, blood vessels, and various other cellular and extracellular elements. It is essential for the development of anti-cancer combination therapies to understand and overcome this high heterogeneity and complexity as well as the dynamic interactions between them within the TME. Recent treatment strategies incorporating immune-checkpoint inhibitors and anti-angiogenic agents have brought many changes and advances in clinical cancer treatment. However, there are still challenges for immune suppressive tumors, which are characterized by a lack of T cell infiltration and treatment resistance. In this review, we will investigate the crosstalk between immunity and angiogenesis in the TME. In addition, we will look at strategies designed to enhance anti-cancer immunity, to convert "immune suppressive tumors" into "immune activating tumors," and the mechanisms by which these strategies enhance effector immune cell infiltration.
引用
收藏
页码:401 / 416
页数:16
相关论文
共 50 条
  • [31] Exploring the crosstalk between endothelial cells, immune cells, and immune checkpoints in the tumor microenvironment: new insights and therapeutic implications
    Fang, Jianwen
    Lu, Yue
    Zheng, Jingyan
    Jiang, Xiaocong
    Shen, Haixing
    Shang, Xi
    Lu, Yuexin
    Fu, Peifen
    CELL DEATH & DISEASE, 2023, 14 (09):
  • [32] Nanotherapeutic approaches targeting angiogenesis and immune dysfunction in tumor microenvironment
    Sadaf Hameed
    Pravin Bhattarai
    Zhifei Dai
    Science China(Life Sciences) , 2018, (04) : 380 - 391
  • [33] Glycosylation in the Tumor Microenvironment: Implications for Tumor Angiogenesis and Metastasis
    Chandler, Kevin Brown
    Costello, Catherine E.
    Rahimi, Nader
    CELLS, 2019, 8 (06)
  • [34] The crosstalk between circular RNAs and the tumor microenvironment in cancer metastasis
    Shao, Ying
    Lu, Bingjian
    CANCER CELL INTERNATIONAL, 2020, 20 (01)
  • [35] Crosstalk between Blood Vessels and Tumor Microenvironment
    Hida, Kyoko
    Ohga, Noritaka
    Kurosu, Takuro
    Totsuka, Yasunori
    Shindoh, Masanobu
    ORAL SCIENCE INTERNATIONAL, 2010, 7 (01) : 1 - 10
  • [36] Understanding the crosstalk between immune cells and the tumor microenvironment in cancer and its implications for immunotherapy
    Elemam, Noha Mousaad
    Talaat, Iman Mamdouh
    Assal, Reem Amr
    Youness, Rana A.
    FRONTIERS IN MEDICINE, 2023, 10
  • [37] The crosstalk between ferroptosis and anti-tumor immunity in the tumor microenvironment: molecular mechanisms and therapeutic controversy
    Zheng, Yichen
    Sun, Lingqi
    Guo, Jiamin
    Ma, Ji
    CANCER COMMUNICATIONS, 2023, 43 (10) : 1071 - 1096
  • [38] Metabolic regulatory crosstalk between tumor microenvironment and tumor-associated macrophages
    Chen, Degao
    Zhang, Xiaomei
    Li, Zhongjun
    Zhu, Bo
    THERANOSTICS, 2021, 11 (03): : 1016 - 1030
  • [39] Regulation of Tumor Immune Microenvironment by Sphingolipids and Lysophosphatidic Acid
    Vishwakarma, Supriya
    Arya, Neha
    Kumar, Ashok
    CURRENT DRUG TARGETS, 2022, 23 (06) : 559 - 573
  • [40] The role of innate immune cells in the tumor microenvironment and research progress in anti-tumor therapy
    Lu, Chenglin
    Liu, Ying
    Ali, Nasra Mohamoud
    Zhang, Bin
    Cui, Xiaonan
    FRONTIERS IN IMMUNOLOGY, 2023, 13